Tuesday, February 22, 2011
The information in quotes has been condensed from an article by Ian Robinson of "Natural Health Dossier Health Watch" (via e-mail):
"...most doctors believe that elevated testosterone levels cause prostate cancer cells to grow. ...But emerging research says the exact opposite is true. ... In fact, higher levels can actually reverse the growth of cancer cells. ..."
"The study comes from Dr. Abraham Morgantaler...a Clinical Professor of Surgery at Harvard Medical School...And a practicing urologist at Beth Israel Deaconess Medical Center in Boston. During his career he also founded Men's Health Boston. Which focuses on male sexual health."
"Dr. Morgentaler has just ... unveiled [his findings] to the American Urology Association (AUA) in San Francisco. His peers are now calling him a 'visionary.' ...he says his theory is simple logic. ...Prostate cancer is an older man's problem. And younger men have much more testosterone than older men."
"'Prostate cancer becomes prevalent exactly at the time of a man's life when testosterone levels decline,' says Dr. Morgentaler. ...[Therefore] too little testosterone is the problem."
"Dr. Morgentaler's breakthrough began in 2004. ... an 84-year-old man came in with untreated prostate cancer. Doctor and patient began talking about [the doctor's theory]. ...By the end of the conversation, his patient ... asked to be treated with testosterone. So together they began testing out the treatment."
"They couldn't believe the results. Dr. Morgentaler watched his 'special' patient closely over two years. And during that time his PSA levels declined. More and more each month. The cancer stopped growing. In fact, it went into remission..."
"Eager to get the word out there, Dr. Morgentaler wrote up his findings in the Harvard Medical Gazette. ...There was still plenty of resistance to his radical approach. But that didn't stop Dr. Morgentaler. And even though it's taken another seven years... his peers are beginning to support his findings."
The newsletter has promised a Part 2.